Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,840 | 7,299 | 7,824 | 8,983 | 9,776 |
| TOTAL | $7,028 | $8,015 | $8,376 | $9,587 | $11,257 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,018 | 1,018 | 1,018 | 1,018 | 704 |
| TOTAL | $1,018 | $1,018 | $1,018 | $1,018 | $704 |
| Total Assets | $8,046 | $9,033 | $9,394 | $10,605 | $11,961 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 243 | 284 | 211 | 241 | 449 |
| Accrued Expenses | 766 | 1,304 | 506 | 569 | 620 |
| TOTAL | $1,009 | $1,588 | $717 | $810 | $1,069 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,009 | $1,588 | $717 | $810 | $1,069 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,542 | 1,542 | 1,541 | 1,541 | 1,541 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -196,140 | -195,703 | -194,429 | -193,234 | -192,063 |
| Other shareholders' equity | -27 | -27 | -27 | -27 | -27 |
| TOTAL | $7,037 | $7,446 | $8,678 | $9,796 | $10,893 |
| Total Liabilities And Equity | $8,046 | $9,033 | $9,394 | $10,605 | $11,961 |